Daniel R. Omstead Acquires 10,096 Shares of Tekla Life Sciences Investors (NYSE:HQL) Stock

Tekla Life Sciences Investors (NYSE:HQL – Get Free Report) President Daniel R. Omstead bought 10,096 shares of the firm’s stock in a transaction on Monday, September 25th. The stock was bought at an average cost of $12.39 per share, for a total transaction of $125,089.44. Following the transaction, the president now directly owns 197,518 shares […]

Related Keywords

Danielr Omstead , ,Wedbush Securities Inc ,Wolverine Asset Management ,Tekla Life Sciences Investors Dividend Announcement ,Raymond James Trust ,Tekla Life Sciences Investors Price Performance ,Tekla Life Sciences Investors ,Tekla Capital Management ,Shaker Financial Services ,Raymond James Associates ,Get Free Report ,President Daniel ,Life Sciences Investors ,Asset Management ,Financial Services ,Tekla Life Sciences Investors Daily ,Nyse Hql ,Whql ,Finance ,Insider Trading ,Nsider Trades ,Stocks ,